ArticleMolecular therapy. Nucleic acids2025
Cell-penetrating antibody enhances nuclear delivery of triplex-forming oligonucleotides targeting HER2-positive cancers.
Anthony Minnah et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.